2,2'-((5S,8R,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S,44R)-14-benzyl-20-sec-butyl-44-carbamoyl-17,26-bis(3-guanidinopropyl)-5,29-bis(4-hydroxybenzyl)-8,32,38,41-tetrakis(hydroxymethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39,42-tetradecaoxo-23-(4-(2,2,2-trifluoroacetamido)butyl)-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40,43-tetradecaazacyclopentatetracontane-11,35-diyl)diacetamide (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View 2,2'-((5S,8R,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S,44R)-14-benzyl-20-sec-butyl-44-carbamoyl-17,26-bis(3-guanidinopropyl)-5,29-bis(4-hydroxybenzyl)-8,32,38,41-tetrakis(hydroxymethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39,42-tetradecaoxo-23-(4-(2,2,2-trifluoroacetamido)butyl)-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40,43-tetradecaazacyclopentatetracontane-11,35-diyl)diacetamide's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

Source	Relation	Target	Evidence
2,2'-((5S,8R,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S,44R)-14-benzyl-20-sec-butyl-44-carbamoyl-17,26-bis(3-guanidinopropyl)-5,29-bis(4-hydroxybenzyl)-8,32,38,41-tetrakis(hydroxymethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39,42-tetradecaoxo-23-(4-(2,2,2-trifluoroacetamido)butyl)-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40,43-tetradecaazacyclopentatetracontane-11,35-diyl)diacetamide Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	NAD-dependent protein deacetylase sirtuin-3, mitochondrial Protein (Entity type)	IC50
2,2'-((5S,8R,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S,44R)-14-benzyl-20-sec-butyl-44-carbamoyl-17,26-bis(3-guanidinopropyl)-5,29-bis(4-hydroxybenzyl)-8,32,38,41-tetrakis(hydroxymethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39,42-tetradecaoxo-23-(4-(2,2,2-trifluoroacetamido)butyl)-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40,43-tetradecaazacyclopentatetracontane-11,35-diyl)diacetamide Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	NAD-dependent protein deacetylase sirtuin-1 Protein (Entity type)	IC50
2,2'-((5S,8R,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S,44R)-14-benzyl-20-sec-butyl-44-carbamoyl-17,26-bis(3-guanidinopropyl)-5,29-bis(4-hydroxybenzyl)-8,32,38,41-tetrakis(hydroxymethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39,42-tetradecaoxo-23-(4-(2,2,2-trifluoroacetamido)butyl)-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40,43-tetradecaazacyclopentatetracontane-11,35-diyl)diacetamide Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	NAD-dependent protein deacetylase sirtuin-2 Protein (Entity type)	IC50